EKF Diagnostics Investor Announcements


EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

6th Sep 2017

EKF Diagnostics Holdings plc announces that the reduction of the Company's share capital has now been approved by the court.

EKF Diagnostics Holdings plc announces that it will release its interim results for the six months ended 30 June 2017 on Monday 11 September 2017.

Standard form for notification of major holdings

Standard form for notification of major holdings 

Resolutions to cancel the share premium account of the Company and to grant the Company the general authority to make market purchases of its own shares were passed.

Notification of major holdings.

6th Jul 2017

The Company is pleased to announce that the trading in the second quarter of the year has continued the favourable trends experienced in the first quarter.

26th Jun 2017

EKF Diagnostics announces that a general meeting of the Company will be held on 27th July 2017.

EKF Diagnostics announces that 21,614,766 share options over ordinary shares have been cancelled.

10th May 2017

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.